Introduction
The molecular biology of red blood cell antigens and the benefits of molecular immunohematology, as compared to important limitations in hemagglutination-based testing, have been explained and described extensively in the last couple of years by several authors [1] [2] [3] [4] [5] [6] . Blood group genotyping is rapidly and successfully making its way into transfusion medicine. Various laboratories such as reference laboratories, donor centers and transfusion services are evaluating how to implement the newly emerging technologies and, most importantly, which molecular technique is best suited to their specific needs [4] [5] [6] .
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Summary
Background In a previous publication we described a method for Jk Here, an improved version of the assay is presented. Methods: Two multiplex polymerase chain reactions (PCR) were developed: one for amplification of samples routinely tested and the other for those systems that are tested less frequently. Each biotinylated PCR product is hybridized in a single multiplex assay. A total of 2,020 samples were analyzed, and the genotypes were compared to the blood group phenotypes. Results: There have been no discrepancies with the serology results other than null and/or weak phenotypes. Conclusion: In its present form, the method presented here has the capacity to genotype hundreds of a samples in few hours with a high concordance rate with serology. 
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Material and Methods
DNA Isolation
Genomic DNA was isolated from peripheral blood samples with a DNA blood kit (QIAamp 96, Qiagen GmbH, Hilden, Germany) or by automated extraction (GenoM-6, Qiagen GmbH).
DNA Amplification by Polymerase Chain Reaction (PCR)
Two multiplex PCR reactions were set up. The PCRs were divided on the basis of the frequency of use in our laboratory and, therefore, the utility of the reactions. PCR (I) amplified the systems for which samples were tested on a routine basis and PCR (II) amplified those systems that were tested less frequently (table 1) . Both PCR reactions were carried out using the same PCR parameters as for the single PCRs 
Discussion
In this paper, we present an updated version of a previously published method [4, 5] for identifying blood group single nucleotide polymorphisms. The number of PCR reactions was reduced by setting up 2 multiplex reactions in order to minimize laboriousness and hands-on time. The PCRs were divided on the basis of the frequency of use in our laboratory and, therefore, the utility of the reactions.
With current assay conditions we can genotype 96 samples (one 96-well plate) per blood group in approximately 4 h with about 1 h of operator time, DNA isolation time excluded. With two 96-well plates, 192 samples may be typed simultaneously without causing a significant increase in total time required. The use of 384-well plates could further increase productivity.
In the last 2 years, we successfully typed more than 2,000 subjects. One limitation of the method, in its present version, is the inability to detect null and/or weak phenotypes. As a matter of fact, in the series of subjects tested we have found 1 Co(a-b-) [10] , 74 Fy b weak , 54 Fy(a-b-) phenotypes which would remain undetected using Luminex alone.
Although multiplexing greatly increases throughput, the use of multiplexing, in our opinion, is not advisable when a donor cohort must be screened for a specific phenotype. Nevertheless, due to the flexibility of this typing approach, multiplexed or separate PCR reactions can be chosen, depending on the specific requirements of the laboratory, in order to rapidly screen a large number of donors.
Disclosure
The authors certify that they have no competing financial interest.
F.D., K.K. and F.P. have applied for a patent related to the work that is described in the present study.
volume was 50 l. PCR was performed with a Mastercycler epgradient S (Eppendorf AG, Hamburg, Germany) with the following program: 94 °C for 2 min, 35 amplification cycles at 94 °C for 20 s, 60 °C for 20 s and 72 °C for 30 s as well as the final elongation step at 72 °C for 5 min.
Hybridization and Analysis of Fluorescence Emission
5 μl of each biotinylated amplicon of PCR (I) and (II) was transferred to 96-well plates (96-well PCR Thermo-Fast ® 96, low profile ABgene; Epsom, UK) and hybridized in a single multiplex assay at 52 °C (Hyb (I)) and at 58 °C (Hyb (II)) (table 2) with the corresponding probe mixture for 15 min. Hybridization was performed according to the procedure described by Karpasitou et al. [4] . Each probe was covalently coupled to a different set of fluorescent polystyrene carboxylated microspheres, purchased internally labeled and ready to couple from the Luminex Corporation, by a carbodiimide method in separate reactions [8, 9] .
In order to optimize hybridization conditions with respect to what has been previously published [4] , probes were modified in their length (probes specific for Jk a , Jk b from 18 to 20 nucleotides, and for K from 18 to 17 nucleotides). Moreover, probes for Lu a , Lu b were extended from 18 to 20 nucleotides.
Detection and analysis of the fluorescence emission was performed using the Luminex 100 analyzer. In the present formulation of our typing system, the allelic ratios were recalculated, and the cut-off ranges were reset [4] .
Samples of 2,020 subjects (blood donors and patients) were typed.
Results
Samples of 2,020 subjects were successfully typed. The concordance between the method presented here and serology was 100% for all alleles phenotypically expressed. One Co (a-b-), 74 Fy b + weak and 56 Fy(a-b-) phenotypes were detected only with serology.
